tenofovir disoproxil fumarate
tenofovir disoproxil fumarate is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including tenofovir disoproxil fumarate, TENOFOVIR DISOPROXIL FUMARATE. Available dosage forms: tablet, film coated, powder, tablet, tablet, coated.
Drug details
- Generic Name
- tenofovir disoproxil fumarate
- Brand Names
- tenofovir disoproxil fumarate, TENOFOVIR DISOPROXIL FUMARATE
- Application Number
- ANDA203232
- Sponsor
- Major Pharmaceuticals
- NDC Codes
- 7
- Dosage Forms
- TABLET, FILM COATED, POWDER, TABLET, TABLET, COATED
- Routes
- ORAL
- Active Ingredients
- TENOFOVIR DISOPROXIL FUMARATE
Indications and Usage
1 INDICATIONS AND USAGE Tenofovir disoproxil fumarate is a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor and is indicated: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 35 kg. ( 1.1 ) for the treatment of chronic hepatitis B in adults and pediatric patients 2 years and older weighing at least 35 kg. ( 1.2 ) 1.1 HIV-1 Infection Tenofovir disoproxil fumarate is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients 2 years of age and older weighing at least 35 kg. 1.2 Chronic Hepatitis B Tenofovir disoproxil fumarate is indicated for the treatment of chronic hepatitis B virus (HBV) in adults and pediatric patients 2 years of age and older weighing at least 35 kg.